Found: 78
Select item for more details and to access through your institution.
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e244170, doi. 10.1001/jamanetworkopen.2024.4170
- By:
- Publication type:
- Article
Outcome of infants and young children with newly diagnosed ependymoma treated on the 'Head Start' III prospective clinical trial.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 2, p. 285, doi. 10.1007/s11060-013-1111-9
- By:
- Publication type:
- Article
Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation.
- Published in:
- Pediatric Pulmonology, 2015, v. 50, n. 6, p. 596, doi. 10.1002/ppul.23034
- By:
- Publication type:
- Article
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.
- Published in:
- Journal of Surgical Oncology, 2023, v. 127, n. 5, p. 871, doi. 10.1002/jso.27205
- By:
- Publication type:
- Article
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 733, doi. 10.1093/jnci/djad055
- By:
- Publication type:
- Article
Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 4, p. 221, doi. 10.2165/11597740-000000000-00000
- By:
- Publication type:
- Article
Advances in Therapy for Pediatric Sarcomas.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 8, p. 1, doi. 10.1007/s11912-014-0395-z
- By:
- Publication type:
- Article
Metabolic response as assessed by <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 857, doi. 10.1002/cam4.3667
- By:
- Publication type:
- Article
A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068416
- By:
- Publication type:
- Article
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2493, doi. 10.1002/cncr.35276
- By:
- Publication type:
- Article
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1735, doi. 10.1002/cncr.34723
- By:
- Publication type:
- Article
Patients with completely resected nongenitourinary low‐risk embryonal rhabdomyosarcoma are candidates for reduced duration low‐intensity chemotherapy.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 23, p. 4150, doi. 10.1002/cncr.34497
- By:
- Publication type:
- Article
Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 946, doi. 10.1002/cncr.33334
- By:
- Publication type:
- Article
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 2, p. 275, doi. 10.1002/cncr.33275
- By:
- Publication type:
- Article
Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31200
- By:
- Publication type:
- Article
Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 7, p. 1, doi. 10.1002/pbc.31009
- By:
- Publication type:
- Article
Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30961
- By:
- Publication type:
- Article
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 4, p. 1, doi. 10.1002/pbc.30847
- By:
- Publication type:
- Article
Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 12, p. 1, doi. 10.1002/pbc.30701
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30556
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30556
- By:
- Publication type:
- Article
Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate‐risk rhabdomyosarcoma: A report from Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30436
- By:
- Publication type:
- Article
TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30413
- By:
- Publication type:
- Article
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 7, p. 1, doi. 10.1002/pbc.30357
- By:
- Publication type:
- Article
Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 6, p. 1, doi. 10.1002/pbc.30293
- By:
- Publication type:
- Article
Advances in the clinical management of high‐risk Wilms tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30342
- By:
- Publication type:
- Article
Advances in the clinical management of high‐risk Wilms tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 3, p. 1, doi. 10.1002/pbc.30153
- By:
- Publication type:
- Article
Clinical and molecular features of pediatric cancer patients with Lynch syndrome.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 11, p. 1, doi. 10.1002/pbc.29859
- By:
- Publication type:
- Article
Comment on: Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low‐risk clinical trials.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 7, p. 1, doi. 10.1002/pbc.29554
- By:
- Publication type:
- Article
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
- Published in:
- 2022
- By:
- Publication type:
- journal article
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 4, p. 1, doi. 10.1002/pbc.29511
- By:
- Publication type:
- Article
Pediatric liposarcoma: A case series and literature review.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 12, p. 1, doi. 10.1002/pbc.29327
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low‐risk clinical trials: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28914
- By:
- Publication type:
- Article
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28832
- By:
- Publication type:
- Article
Treatment of central giant cell granuloma in children with denosumab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 1, p. 1, doi. 10.1002/pbc.28741
- By:
- Publication type:
- Article
Comment on: Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
- Published in:
- 2020
- By:
- Publication type:
- letter
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Congenital spindle cell rhabdomyosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Alveolar soft part sarcoma in children and young adults: A report of 69 cases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article